Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Irritable Bowel Syndrome With Constipation · Chronic Constipation · IRWD

IRONWOOD PHARMACEUTICALS

IRONWOOD PHARMACEUTICALS INC

IRONWOOD PHARMACEUTICALS patent portfolio — 45 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
100 Summer Street, Boston, MA 02110, US HQ
1998 Founded
262 Employees
Public company Type
IRWD · NYSE Ticker
Company details
Status
Public
HQ
100 Summer Street, Boston, MA 02110, US
Founded
1998
Employees
262
Programs
33
Drugs
11
Patents
45
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

IRONWOOD PHARMACEUTICALS patents

45 pharmaceutical patents indexed for IRONWOOD PHARMACEUTICALS. 0 expire within 24 months.

IRONWOOD PHARMACEUTICALS has 45 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

45 patents

Patent portfolio

  1. US 10702576

    Stable formulations of linaclotide

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10675325

    Stable formulations of linaclotide

    Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10618938

    Compositions for colon cleansing and the treatment of gastrointestinal disorders

    Expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10266529

    Salts, co-crystals, and polymorphs of an anxiolytic compound

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10189809

    SGC stimulators

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10183021

    sGC stimulators

    Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10047095

    sGC stimulators

    Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9969742

    Imidazotriazinone compounds

    Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9840536

    Methods and compositions for the treatment of gastrointestinal disorders

    Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9745296

    Salts, co-crystals, and polymorphs of an anxiolytic compound

    Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9725453

    Imidazotriazinone compounds

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9708371

    Treatments for gastrointestinal disorders

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9657012

    FAAH inhibitors

    Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9650417

    Treatments for gastrointestinal disorders

    Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9617305

    Treatments for gastrointestinal disorders

    Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9586937

    sGC stimulators

    Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9540380

    Imidazotriazinone compounds

    Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9527887

    Treatments for gastrointestinal disorders

    Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9487508

    SGC stimulators

    Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9481689

    sGC stimulators

    Expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9309235

    SGC stimulators

    Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9303066

    Treatments for gastrointestinal disorders

    Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9205094

    Compositions comprising bile acid sequestrants for treating esophageal disorders

    Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9139564

    2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulators

    Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9061030

    sGC stimulators

    Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9024069

    NONOate derivatives and uses thereof

    Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8946158

    Treatments of gastrointestinal disorders

    Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8933030

    Treatments for gastrointestinal disorders

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8884020

    Indole compounds

    Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8802628

    Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration

    Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8779090

    Methods and compositions for the treatment of heart failure and other disorders

    Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8748442

    sGC stimulators

    Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8748573

    Formulations comprising linaclotide

    Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8735360

    Treatments for gastrointestinal disorders

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8674115

    CRTH2 modulators

    Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8507447

    Treatments for gastrointestinal disorders

    Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8110553

    Methods and compositions for the treatment of gastrointestinal disorders

    Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8101579

    Methods and compositions for the treatment of gastrointestinal disorders

    Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8088935

    Compounds and methods for the treatment of asthma

    Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8080526

    Methods and compositions for the treatment of gastrointestinal disorders

    Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7910546

    Methods and compositions for the treatment of gastrointestinal disorders

    Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7772188

    Methods and compositions for the treatment of gastrointestinal disorders

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7745409

    Methods and compositions for the treatment of gastrointestinal disorders

    Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7704947

    Methods and compositions for the treatment of gastrointestinal disorders

    Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7494979

    Method for treating congestive heart failure and other disorders

    Expires Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does IRONWOOD PHARMACEUTICALS have?

45 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do IRONWOOD PHARMACEUTICALS patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.